CPRX..$2.89..I see any pullback being bought here. There is a 20.8% short position on the stock. This stock has catalysts in October and Q4. They also have the breakthrough designation. Shorts trying to put a lid on this are having a hard time. 2 days to cover a 21% short position is not very many days thus the sharp increases in price the past few days as we move closer to the catalysts.
Data Monitoring Committee • DMC charter includes analyses of unblinded safety and efficacy data – Safeguard interests of study participants – Assess the continuing safety & efficacy • i.e. benefit of participation continues to outweigh risks – Provide recommendations for conduct of study – Provide recommendations for continuing or stopping study • Observations and recommendations from latest meeting (03/25/13) – To continue the trial as planned and without changes to the protocol – To continue encouraging greater enrollment rate by adding sites • Next scheduled meeting October, 2013